A recent report published by Infinium Global Research on
diagnostic specialty antibodies market provides an in-depth analysis of segments
and sub-segments in the global as well as regional diagnostic specialty
antibodies market. The study also highlights the impact of drivers, restraints,
and macro indicators on the global and regional diagnostic specialty antibodies
market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global diagnostic
specialty antibodies market. According to the report, the global diagnostic
specialty antibodies market is projected to grow at a CAGR of 5.2% over the
forecast period of 2019-2025.
The growing patient pool of HIV diagnosis is one of the major
factors for the growth of the diagnostic specialty antibodies market across the
globe. According to the World Health Organization, an estimated 1.1 million
people aged 13 and older had HIV infection in the United States in 2016,
including an expected 162,500 (14%) people whose infections had not been
diagnosed. In 2017, the sum of new HIV diagnoses in the United States and 6
dependent areas were 38,739. Furthermore, high unmet needs in the market,
advanced research and developments are the other key factors that boost the
growth of the diagnostic specialty antibodies market. However, the failure of
antibodies in a rapid diagnostic test for routine diagnosis and high cost of
monoclonal antibodies are some of the major factors that may restrain the
market growth over the forecast period. Moreover, the launch of novel products
and technological advancements creates beneficial opportunities for diagnostic
specialty antibodies market in the upcoming years.
In terms of region, North America is leading the diagnostic
specialty antibodies market during the forecast period. This is primarily due
to the growing demand for specialty antibody diagnostics for human
immunodeficiency virus (HIV), hepatitis delta virus (HDV), and another
infectious disease diagnosis. Furthermore, the increase in the adoption of
various antibody kits in hospitals and private clinics also helps in the growth
of diagnostic specialty antibodies market in the North American region. On the
other hand, Europe is expected to be the second-largest region in the
diagnostic specialty antibodies market over the forecast period. The surge in
the frequency of infectious diseases, a large patient pool for HIV diagnosis
are some key factors for the growth of the market in the region. In addition,
the availability of technologically advanced research and development platforms
for the diagnosis of disorders and the launch of innovative and advanced kits
by major manufacturers also boosts the market growth in the European region.
The report on global diagnostic specialty antibodies market covers
segments such as an antibody, application, and end user. On the basis of antibody,
the sub-markets include polyclonal antibodies, monoclonal antibodies, and
recombinant polyclonal antibodies. On the basis of application, the sub-markets
include tuberculosis diagnostics, hepatitis diagnosis, dengue diagnostics, HIV
diagnostics, infectious disease diagnostics, oncology diagnostics, and other
application. On the basis of end user, the sub-markets include hospitals,
diagnostic laboratories, and other end users.
The report provides profiles of the companies in the market such
as F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Abcam plc.
Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Boehringer Ingelheim
International GmbH, Agilent Technologies, Inc., Aytu BioScience, Inc., and
Polymun Scientific Immunbiologische Forschung GmbH.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of diagnostic
specialty antibodies market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.